McMillan Shakespeare Limited shares climb: Have you missed all the gains?

Profits down 10%, but a better year ahead beckons

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

McMillan Shakespeare Limited's (ASX: MMS) shares climbed as much as 9% higher in early morning trade, but have since retreated to be around 3% up.

The salary packaging and financing company today reported a net profit after tax of $55 million, 12% lower than the previous year, due to a temporary disruption caused by the previous government's proposed changes to fringe benefits tax (FBT).

McMillan declared a final dividend of 31 cents per share, taking the full 2014 financial year dividend to 52 cents, putting the company on a fully franked dividend yield of 4.7%.

The company divides its business into two segments, Group Remuneration Services (GRS) and Asset Management (AM).  Asset Management includes the group's UK business.

GRS full year net profit was down 10% to $42 million, thanks mainly to higher employee expenses. Pleasingly, the second half was very strong, with net profit up 16% over the previous year.

The AM business saw net profit fall 7% to $14.0 million, mostly as a result of depreciation costs associated with a new asset management system. McMillan says the UK business is expected to turn profitable this year, and says it has entered the UK market at a fortuitous time. The company says the UK economy is gathering momentum and there's a favourable tax ruling on the proposed car salary sacrifice product.

Looking to 2015, McMillan says it expects to see another year of profitable growth in 'all lines of business'. The company says it will launch new products into both the Australian and UK markets this financial year. Bolt-on acquisitions could be on the cards with $71 million in cash in the bank, although the company has slightly increased its borrowings to $144 million, from $125 million last year.

With the FBT debacle behind it, McMillan Shakespeare appears set for a strong year in 2015, although it faces some competition in ASX-listed  Smartgroup Corporation Ltd (ASX: SIQ) and to a lesser extent SG Fleet Group Ltd (ASX: SGF). At current prices the company is trading on an undemanding P/E ratio of 14.6x, and paying a 4.7% fully franked dividend yield.

If this company doesn't float your boat, here's two more ideas for you…

Motley Fool writer/analyst Mike King owns shares in McMillan Shakespeare. You can follow Mike on Twitter @TMFKinga

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »